Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-24 @ 11:59 AM
NCT ID:
NCT00956761
Eligibility Criteria:
Key Inclusion Criteria:
* Subjects of 65 years of age or older
* Mentally competent
* Willing and able to give written informed consent prior to study entry
* Able to comply with all the study requirements
* In general good health
Key Exclusion Criteria:
* Any serious chronic or acute disease disease
* History of any anaphylactic reaction and/or serious allergic reaction following a vaccination
* A proven hypersensitivity to any component of the study vaccine
* Known or suspected (or have a high risk of developing) impairment/alteration of immune function (excluding that normally associated with advanced age)
* Bleeding diathesis or conditions associated with prolonged bleeding time that in the investigator's opinion would interfere with the safety of the subject
* Within the past 12 months, participants had received more than one injection of influenza vaccine
* Within the past 6 months, participants had laboratory confirmed influenza disease or received influenza vaccine
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00956761
Study Brief:
Protocol Section:
NCT00956761